Outcomes

PROVEN OUTCOMES.* BEYOND TRIALS.


Celebrating over 180,000 patients globally on the Medtronic MiniMed 670G system with over two years in the market. Our real-world data shows over 71%* Time in Range.

2+ years in the market^
8 Million days of patient data*
71% Time in Range*

0
180,000+^
Patients on Medtronic
Hybrid Closed Loop*
Other Hybrid
Closed Loops
MiniMed 670G
System
* Refers to Time in Range of 71% obtained from data from CareLink software uploads in the US from March 2017 to March 2019; patient days = 7,984,915.
^ Data on File. Based on shipped units.


ACRONYMS: MDI: Multiple Daily Injections, SMBG: Self-Monitoring of Blood Glucose, CGM: Continuous Glucose Monitoring, CSII: Continuous Subcutaneous Insulin Infusion., SAP: Sensor Augmented Pump, TIR: Time in Range
Lows
Highs